![Todd Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Simpson
Director/Board Member at
XENCOR, INC.
Net worth: 284 977 $ as of 2026-05-30
Profile
Presently, Todd E. Simpson is Chairman for Neoleukin Therapeutics, Inc. and Chief Financial Officer for Seagen Inc. Mr. Simpson is also on the board of Cascadian Therapeutics, Inc. and Washington Biotechnology & Biomedical Association. In his past career he held the position of CFO, VP-Finance & Administration at Vericel Corp., Treasurer at Integra LifeSciences Holdings Corp. and Chief Financial Officer & Vice President of Telios Pharmaceuticals, Inc. (a subsidiary of Integra LifeSciences Holdings Corp.), CFO & VP-Finance & Administration at AmpliPhi Biosciences Corp. and Principal at Ernst & Young LLP. He received an undergraduate degree from Oregon State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XENCOR, INC. 0.03% | 2026-06-15 | 23,988 ( 0.03% ) | 284 977 $ | 2026-05-30 |
Latest news about Todd Simpson
Todd Simpson active positions
| Companies | Position | Start |
|---|---|---|
| XENCOR, INC. | Director/Board Member | 2025-03-12 |
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Director/Board Member | 2024-06-24 |
Inovia Capital (US), Inc.
 Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Consultant / Advisor | 2016-12-31 |
Former positions of Todd Simpson
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Director of Finance/CFO | 2022-12-13 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Director of Finance/CFO | 2005-09-30 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Director of Finance/CFO | 2001-09-30 |
| VERICEL CORPORATION | Director of Finance/CFO | 2001-09-30 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Treasurer | 1995-11-30 |
Training of Todd Simpson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Oregon State University
 Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Inovia Capital (US), Inc.
Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
- Stock Market
- Insiders
- Todd Simpson
Choose MarketScreener 
